CISPLATIN + AZD-1775 In Breast Cancer

Clinical trial NCT03012477 · COMPLETED

Trial details

NCT number: NCT03012477
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Triple-negative Metastatic Breast Cancer

Start date: 2017-01-18
Primary completion: 2019-05-07
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.